Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Islet Transplantation Using Abatacept
NCT00276250Phase 2Completed
- Sponsor
- Emory University
- Start
- Dec 2005
- Primary completion
- Dec 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, open-label trial of abatacept in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Emory University. Primary endpoint: Number of Insulin-independent Subjects at 75 days. Started Dec 2005; status: completed.
02
Drugs
abatacept
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00276250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276250.